跳至主要内容
临床试验/CTRI/2020/01/022839
CTRI/2020/01/022839尚未招募2 期

A clinical study to evaluate the add on effectiveness of Palandu peya in Raktapradara(Menorrhagia).

Dr Reshma Shaji1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2020年1月17日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
A Clinical study to evaluate the add on effectiveness of Palandu peya as a pathya in the management of raktapradara(menorrhagia)

研究概览

简要总结

Pathya (therapeutic diet) plays a key role inthe  management of diseases. Raktapradara (Menorrhagia) is mainly oneof those diseases found in women of reproductive age group where excessivebleeding during menstrual cycle(>80 ml) is the main symptom. It is clearlystated in classics that the disease is specifically due to consumption ofunsuited or unwholesome  food. Palandupeya mentioned as pathya in raktapradara is expected to decrease the excessivebleeding through vagina and thereby reducing the complications like anemia. Theingredients of this are easily available, and can easily be prepared at home. The ingredients include palandu, surasa leaves, tila taila, go ghrta, shali and jala. Keeping in view these facts, this study is conducted to evaluate the add oneffectiveness of  palandu peya inraktapradara.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Open Label

入排标准

年龄范围
12.00 Year(s) 至 50.00 Year(s)(—)
性别
Female

入选标准

  • Subjects presenting with prolonged or excessive bleeding through vagina in normal cycles in at least past two cycles.
  • Subjects in reproductive age group.
  • Subjects ready to sign informed consent form.

排除标准

  • Subjects with history of coagulation or fibrinolytic disease.
  • Known case of sexually transmitted diseases.
  • Subjects usually intrauterine devices and hormonal pills.
  • History of malignancies.
  • Diagnosed case of Inflammatory bowel disease.

结局指标

主要结局

A Clinical study to evaluate the add on effectiveness of Palandu peya as a pathya in the management of raktapradara(menorrhagia)

时间窗: Assessment will be done on baseline treatment,assessed on 15 th day and after completion of study on 31st day.

次要结局

  • to reduce excessive bleeding and thereby preventing complications like anemia.(15 th day and after completion of study.)

研究者

发起方
Dr Reshma Shaji
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验